Contract Manufacturing

‘A win-win situation’: Terumo CDMO invests in parenteral drug services

07-Nov-2022 By Maggie Lynch

Japanese CDMO expands services to meet demand for parenteral drugs for global customers.

Charles River wins gene therapy manufacturing contract from Nanoscope

07-Nov-2022 By Nick Taylor

Charles River Laboratories’ growing gene therapy manufacturing capabilities have landed it a deal with the eye disease biotech Nanoscope Therapeutics.

Corium sells off CDMO business for $400m

27-Oct-2022 By Ben Hargreaves

The company will split into two separate entities, one will focus on the development of neuroscience therapies and the other will become a standalone CDMO.

‘Innovators need to meet contract services partners sooner, plan much earlier and far further into development’

26-Oct-2022 By Rachel Arthur

A ‘significant shift’ is under way in global outsourcing strategies: with the sector moving away from phase-appropriate development in favor of a more forward-looking model – with experts advising starting the search for an outsourcing partner as early...

CPHI Pharma Award finalists announced

26-Oct-2022

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

Adragos snaps up Sanofi’s Japanese manufacturing facility

24-Oct-2022 By Ben Hargreaves

The German CDMO signs an agreement to acquire Sanofi’s Kawagoe-based facility, which adds to the company’s existing presence in the country.

WuXi fills ‘capacity gap’ with HP facility in Wuxi city

04-Oct-2022 By Maggie Lynch

WuXi STA continues its growth and opens its first high potency oral drug product manufacturing facility at its Wuxi city campus.

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Lonza expanding dry powder inhalation capabilities at Florida site

01-Sep-2022 By Jenni Spinner

In response to rising demand for inhalable treatments geard toward respiratory conditions, the company is adding capabilities and capacity at its Tampa site.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

New WuXi STA plant to tackle growing HPAPI demand

31-Aug-2022 By Jenni Spinner

A company leader advises that the growing need for high-potency active pharmaceutical ingredients calls for CDMOs that consistently deliver quality at scale.

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Charles River opens research facilities in California and Washington

30-Aug-2022 By Jane Byrne

Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

UPS acquires multi-national healthcare logistics company Bomi

15-Aug-2022 By Jenni Spinner

The purchase brings under the UPS Healthcare umbrella several temperature-controlled facilities in 14 countries situated throughout Europe and Latin America.

Pharmanovia taps Nanoform to improve bioavailability of ‘iconic branded medicine’

08-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the nanotechnology specialist to use nanoparticle tech and formulation to advance its products.

People on the Move: August 2022

04-Aug-2022 By Jenni Spinner

This month’s announcements of appointments, partnerships, expansions, and mergers include Curia, Thread, TFF Pharmaceuticals, and other notable companies.

Blending human knowhow, artificial intelligence aids drug discovery

02-Aug-2022 By Jenni Spinner

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics.

Novasep-PharmaZell commits nearly$7.5m to boosting API capacity

01-Aug-2022 By Jenni Spinner

The contract development and manufacturing organization plans to invest €7.3m to expand and upgrade API production capacity at its Mourenx, France facility.

Tech Innovations: July 2022

21-Jul-2022 By Jenni Spinner

This month’s announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

Will biotech see an uptick in M&A?

19-Jul-2022 By Rachel Arthur

The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?

Piramal Pharma Solutions opens doors on API production plant

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization's active pharmaceutical ingredient manufacturing operation is located at its site in Aurora, Canada.

On-demand cleanrooms help pharma manufacturers ‘fail fast’

13-Jul-2022 By Jenni Spinner

A representative from life-science services company Azzur Group explains how flexibility and speed can help in reaching the best solution more efficiently.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Building resilience into biotech supply chains: 'COVID-19 will not be the last major crisis of the 21st century'

08-Jul-2022 By Rachel Arthur

Biotech supply chains face an uncertain future in 2022 and beyond: up against myriad challenges ranging from future pandemic outbreaks to geopolitical tensions – and, indeed, unforeseen threats. Communication and collaboration between policymakers and...

Note from the editor: Small but important changes ahead

30-Jun-2022 By Jenni Spinner

The past two years have been full of shifts and shakes in the drug development field, but the change at Outsourcing-Pharma is easy and one for the better.

EY biotech report checks in on the mood of industry leaders

23-Jun-2022 By Jenni Spinner

The 32nd iteration of the company’s Beyond Borders report offers an in-depth look at the state of the current market landscape, and what’s on the horizon.

Survey: most people believe in need for more cancer research

21-Jun-2022 By Jenni Spinner

A new survey reveals the majority of the general public thinks more cancer research is in order, but many are reluctant to pitch in to the effort financially.

bio 2022

BIO unveils its executive committee directors for 2022-2023 term

16-Jun-2022 By Jenni Spinner

The Biotechnology Innovation Organization elected the fresh slate of leaders during the BIO International Convention, taking place in San Diego this week.

Tech Innovations: June 2022

16-Jun-2022 By Jenni Spinner

This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

bio 2022

Pandemic highlights need for supply chain visibility, partnerships

14-Jun-2022 By Jenni Spinner

During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises.

bio 2022

Lonza opens early-phase development and manufacturing facility in Oregon

14-Jun-2022 By Nick Taylor

The company has completed its early-phase development and manufacturing facility in Bend, giving it 11 processing suites focused on first steps into the clinic.

bio 2022

ten23 adds manufacturing building in rapid build out

14-Jun-2022 By Ben Hargreaves

The newly launched CDMO plans to set up two new manufacturing lines, after expanding into a 5,000-square-meter manufacturing facility.

Advanced tech can thwart site staffing problems: IQVIA

13-Jun-2022 By Jenni Spinner

An expert from the trial tech company discusses tools that can prove useful for trial teams looking to avoid employee shortages plaguing other industries.

bio 2022

BIO panel takes on patient recruitment, retention challenges

09-Jun-2022 By Jenni Spinner

Representatives from Clincierge, Rare Patient Voice, Insight and Measurement, and Ultragenyx Pharmaceutical will lead the lively panel discussion on June 13.

dia 2022

Collaboration, innovation to take center stage at DIA 2022

08-Jun-2022 By Jenni Spinner

This year’s DIA Global Annual Meeting (taking place June 19-23 in Chicago) reunites professionals for face-to-face learning and networking opportunities.

dia 2022

DIA offers tracks to deliver focused educational experience

08-Jun-2022 By Jenni Spinner

Offering 13 topic tracks to choose from, the DIA Global Annual Meeting (scheduled June 19-23) lets attendees chose the path that fits their unique interests.

Building in resilience can protect against disruption: Rockwell

08-Jun-2022 By Jenni Spinner

An expert from Rockwell Automation explains how integrating flexibility, using advanced technology, can help pharma manufacturing operations weather a storm.

bio international 2022

BIO International 2022 to bring insights, athletes to San Diego

06-Jun-2022 By Jenni Spinner

Coming back to the real world June 13-16, the industry event will offer face-to-face learning, networking opportunities, and fun, star-studded opportunities.

People on the Move: June 2022

02-Jun-2022 By Jenni Spinner

This month’s announcements of awards, investments, executive appointment, and expansions include Javara, Thread, uMotif, Lonza, and other notable companies.

How Lithuania aims to become a leading European biotech hub

01-Jun-2022 By Ben Hargreaves

Lithuania’s life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the country’s plans are for future growth in the area and how this is built upon students heading into STEM studies.

Lilly invests $2.1bn in new Indiana manufacturing sites

31-May-2022 By Rachel Arthur

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Syneos Health promotes industry veteran to CEO

25-May-2022 By Jenni Spinner

Michelle Keefe, formerly the president of medical affairs and commercial solutions, joined the company in 2017; she also had spent 20 years working for Pfizer

Standigm uses AI to discover potential Crohn’s disease treatment

24-May-2022 By Jenni Spinner

The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohn’s.

ObvioHealth digital tools aim to bring objectivity to pediatric clinical trial assessments

24-May-2022 By Nick Taylor

The virtual research organization has developed digital instruments designed for assessing stools and recording crying episodes in pediatric clinical studies.

NIH awards $577m to antiviral drug developers

20-May-2022 By Rachel Arthur

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Novartis looks to work more strategically as CDMO

16-May-2022 By Jane Byrne

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

Charles River, Valo join on AI-enabled drug discovery offering

10-May-2022 By Nick Taylor

The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.

FDA outlines benefit-risk approach to drug or biologic product quality assessment

10-May-2022 By Jane Byrne

The US FDA released new draft guidance yesterday discussing, among other challenges, how unresolved product quality issues might be addressed in the context of regulatory decision-making.